Year: 2023
Type: article
Source: Nature Chemistry
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: U.S. Department of Defense, Howard Hughes Medical Institute, U.S. Department of Health and Human Services, Broad Institute, National Institutes of Health, Defense Advanced Research Projects Agency, National Human Genome Research Institute, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Biomedical Imaging and Bioengineering
Awards: G1037014486, G1187679441, 'MULTIDIMENSIONAL CHEMOGENIC CONTROL OF CRISPR- NUCLEASES IN CELLS AND ORGANISMS', G1973200330, G2304256781, Development of synthetic gene drives using small molecules, Chemical approaches for precision genome editing, G4630203202, G4883975104, G5052434461, G52289035, G5232001575, G6078497061, G6316350344, G6623355810, G691306909, Continuous Evolution of Proteins with Novel Therapeutic Potential, Degrading therapeutically important kinases using small molecules, G7095660139, G7486275663, G8120716183, G8649764646, Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics, G9000034423, G9000083182, G9000117671, G9000195109, The molecular basis of IMiD induced neo-substrate recruitment to the CRL4CRBN ubiquitin E3 ligase, ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential, G962928493
OpenAlex ID: W4389894233
